Frequency of complete blood counts for patients at risk of heparin-induced thrombocytopenia a review of guidelines
The purpose of this report is to examine recent evidence-based guidelines regarding the use of complete blood counts to monitor for heparin-induced thrombocytopenia in cardiac patients receiving intravenous unfractionated heparin
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa
CADTH
2018, October 2, 2018
|
Edition: | Version 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this report is to examine recent evidence-based guidelines regarding the use of complete blood counts to monitor for heparin-induced thrombocytopenia in cardiac patients receiving intravenous unfractionated heparin |
---|---|
Physical Description: | 1 PDF file (7 pages) illustrations |